Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Long-Term Deferred Tax (2022 - 2023)

Historic Long-Term Deferred Tax for Bicycle Therapeutics (BCYC) over the last 2 years, with Q4 2023 value amounting to $88.6 million.

  • Bicycle Therapeutics' Long-Term Deferred Tax rose 3347.3% to $88.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $88.6 million, marking a year-over-year increase of 3347.3%. This contributed to the annual value of $88.6 million for FY2023, which is 3347.3% up from last year.
  • Latest data reveals that Bicycle Therapeutics reported Long-Term Deferred Tax of $88.6 million as of Q4 2023, which was up 3347.3% from $66.3 million recorded in Q4 2022.
  • Bicycle Therapeutics' 5-year Long-Term Deferred Tax high stood at $88.6 million for Q4 2023, and its period low was $66.3 million during Q4 2022.